Okomera
Latest round
- Seed
Last raised
- Sep 2023
Total raised
- $4.8M
Investors
- 5
About Okomera
Founded in 2020 and based in Paris, France, Okomera SAS operates as a provider of a device that can analyze cancer treatments' effectiveness. Raphaël Tomasi (CTO) and Sandra Jernström (CSO) are the co-founders of the company. The company also has a presence in the US. The company specializes in performing drug discovery through its automated 3D organoid screening technology. The firm’s technology focuses on integrating standard assays on chip, such as CRISPR, T-cell, and cytotoxicity assessments. Okomera's primary focus lies in advancing preclinical predictivity and offering a pathway for the pharmaceutical industry. The company’s technology facilitates screening, amplifying the efficiency of drug screening processes with the ability to handle over 100 conditions per batch. In addition, its features also include miniaturization, which enables the analysis of cellular responses with as few as 5,000 cells per chip. Okomera's partners include institutions like Institut Curie, Gustave Roussy Cancer Campus, Cancer Research UK, Berkeley University, and others.
Who invested in Okomera
5 investors across 1 round
See all investors in Okomera
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 27, 2023
Amount
$4.8M
Investors
Questions about Okomera
Who invested in Okomera?
Okomera has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Okomera raised?
Okomera has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Okomera last raise money?
Okomera's most recent round on record is a Seed, in Sep 2023.
What does Okomera do?
Founded in 2020 and based in Paris, France, Okomera SAS operates as a provider of a device that can analyze cancer treatments' effectiveness.
Where is Okomera headquartered?
Okomera is headquartered in Paris, France.
Which VCs invest in companies like Okomera?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Okomera's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Okomera? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.